TP53 and neoplasm: To identify new genes involved in the cellular response to PARPi in BRCA2;p53-deficient tumours, we performed a genome-wide CRISPR-Cas9 screen in our KB2P3.4 (K14cre;Trp53-/-;Brca2-/-) mouse mammary tumour cell line21.